Sannmerk App

Canonical ingredient

Benzoic acid, 2-hydroxy-5-[[4-[(2-pyridinylamino) sulfonyl]phenyl]azo]-

SULFASALAZINE

13 linked products

Official identifiers

CAS 599-79-1ChEBI CHEBI:9334InChI InChI=1S/C18H14N4O5S/c23-16-9-6-13(11-15(16)18(24)25)21-20-12-4-7-14(8-5-12)28(26,27)22-17-3-1-2-10-19-17/h1-11,23H,(H,19,22)(H,24,25)/b21-20+InChIKey NCEXYHBECQHGNR-QZQOTICOSA-NKEGG_COMPOUND C07316SMILES O=C(O)c1cc(/N=N/c2ccc(S(=O)(=O)Nc3ccccn3)cc2)ccc1O

Names and synonyms

  • Benzoic acid, 2-hydroxy-5-[[4-[(2-pyridinylamino) sulfonyl]phenyl]azo]- (en)
  • sulfasalazine (en)
  • Sulfasalazine (fr)
  • Salazosulfapyridine (fr-CA)

Source-scoped chemical properties

Every value keeps its own authority, licence and retrieval date. Conflicting values are not silently merged.

canada dsl listing
listed
canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
Official record ↗
dsl bioaccumulative
No
canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
Official record ↗
dsl inherently toxic aquatic
No
canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
Official record ↗
dsl meets cepa categorization
No
canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
Official record ↗
dsl meets environmental
No
canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
Official record ↗
dsl meets human health
No
canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
Official record ↗
dsl persistent
No
canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
Official record ↗
dsl substance category
Organics
canada_dsl_categorization · Open Government Licence - Canada 2.0 · 2026-08-03
Official record ↗

Safety and technical documents

General references and manufacturer-specific SDS documents are kept separate.

0 document(s)
No verified SDS or technical sheet is linked yet. This absence is explicit and does not mean that no document exists.

End-to-end traceability

Only links supported by an identified source are published. Missing evidence remains explicitly unknown.

Partial chain

Evidence still missing

  • Country or region of origin
  • Raw-material producer
  • Ingredient manufacturer
  • Distributor
  • Transformation steps

Documented origins

No origin has been proven yet by an explicit source.

Documented organizations

No organization has been proven yet by an explicit source.

Documented transformations

No transformation step has been proven yet by an explicit source.

Method: a company’s registration country is never used as evidence of a material’s origin.

Products containing this ingredient

APO SULFASALAZINE TAB 500MG
500 · MG
JAMP SULFASALAZINE
500 · MG
PMS-SULFASALAZINE 500MG/TAB USP
500 · MG
PMS-SULFASALAZINE-E.C. TAB 500MG
500 · MG
RATIO-SULFASALAZINE EN
500 · MG
RATIO-SULFASALAZINE TAB 500MG
500 · MG
S.A.S. ENTERIC 500MG
500 · MG
SALAZOPYRIN EN-TABS 500 MG
500 · MG
SALAZOPYRIN ENEMA 3.0GM/100ML
3 · G · 100 · ML
SALAZOPYRIN ENEMA 3GM/100ML
3 · G · 100 · ML
SALAZOPYRIN TAB 500MG
500 · MG
SAS ENEMA 3GM/100ML
3 · G · 100 · ML
SAS TAB 500MG
500 · MG